No Prescription |
 |
 | ||
|
Becoderm C Generic Clobetasone Butyrate |
|
| ||
No Prescription » Prescription Drugs 2 » Becoderm C Generic Clobetasone Butyrate BECODERM-C CREAM is used to treat eczema and dermatitis. It can help you to control patches of dry red itchy flaky or inflamed skin caused by eczema and dermatitis.BECODERM-C CREAM contains clobetasone butyrate. Clobetasone butyrate is a topical corticosteroid. It is used to control inflammation of the skin. BECODERM-C CREAM works to stop the skin's over-reaction to the triggers that cause skin flare-ups. It suppresses the inflammation that causes eczema or dermatitis. BECODERM-C CREAM cream base also has moisturising properties.Do not use if you have an allergy to BECODERM-C CREAM or any of the ingredients listed at the end of this leaflet.Do not use the cream on the wrong skin conditions. It could make it worse.If you are not sure what is causing your skin problem ask your pharmacist or doctor.Do not use this cream (or any other corticosteroid) on:Broken or infected skin: like cold sores herpes chicken pox impetigo ringworm athlete's foot or thrush. Psoriasis: this needs to be managed by your doctor. Acne: spots or pimples Seborrhoeic dermatitis: this involves areas of skin where this cream should not be used. Ulcerated skin or if you suffer from poor circulation in the area of skin to be treated. In or near the eyes For more than 7 days unless a doctor has told you to Under waterproof bandages If you have any of these conditions ask your healthcare professional for advice.Do not use other corticosteroids (like hydrocortisone) on the skin while you are using this cream. You would be doubling the dose.Do not use BECODERM-C CREAM after the expiry date (EXP) printed on the pack. If you use this medicine after the expiry date has passed it may not work as well or it may give an entirely unexpected effect.Do not give BECODERM-C CREAM to anyone else even if they have similar symptoms to you.Do not use BECODERM-C CREAM:on children under 12 years of age if you are pregnant or may be pregnant if you are breastfeeding to treat any other conditions other than eczema and dermatitis unless advised by your doctor. Do not use BECODERM-C CREAM if the packaging is torn or shows signs of tampering. Buy Becoderm C Generic Clobetasone Butyrate and other Prescription Drugs 2 products online at Medstore. Buy Online at Medstore - Click Here!
About Becoderm C Generic Clobetasone Butyrate: Product Type: Prescription Drugs 2 Becoderm C ( Generic Clobetasone Butyrate ) Becoderm C (Generic Clobetasone Butyrate) Generic Clobetasone Butyrate 0.05% 15gm Cream 3 x 15gm Cream Generic Clobetasone Butyrate Becoderm C
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
